Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport

ER stress is associated with reduced ABCA-1 protein levels in macrophages treated with advanced glycated albumin – Reversal by a chemical chaperone

(2012) Gabriela Castilho et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Inhibition of Macrophage Oxidative Stress Prevents the Reduction of ABCA-1 Transporter Induced by Advanced Glycated Albumin

(2012) Raphael de Souza Pinto et al.   LIPIDS

Advanced Glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1

(2011) Rodrigo T Iborra et al.   Lipids in Health and Disease

Emerging new paradigms for ABCG transporters

(2009) Paul T. Tarr et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Association between carotid diameter and the advanced glycation endproduct Nepsilon-Carboxymethyllysine (CML)

(2009) Marcus Baumann et al.   Cardiovascular Diabetology

Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus

(2009) Masumi Ai et al.   CLINICA CHIMICA ACTA

Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients

(2009) Kuang-Hsing Chiang et al.   CORONARY ARTERY DISEASE

Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes

(2008) Yasuro Kumeda et al.   CLINICAL ENDOCRINOLOGY